- Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
-
Yang HS, Hur M, Kim H, Magrini L, Marino R, Di Somma S, GREAT Network
- KMID: 2373598
- Ann Lab Med.
- 2016 Nov;36(6):590-594.
- doi: 10.3343/alm.2016.36.6.590
Soluble suppression of tumorigenicity 2 (sST2) has emerged as a biomarker of cardiac stretch or remodeling, and has demonstrated a role in acutely decompensated heart failure. However, its role in... -
- CITED
-
- Close
- SHARE
-
- Close
- Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis
-
Hur M, Kim H, Kim HJ, Yang HS, Magrini L, Marino R, Cardelli P, Di Somma S, GREAT Network
- KMID: 2363259
- Ann Lab Med.
- 2015 Nov;35(6):570-577.
- doi: 10.3343/alm.2015.35.6.570
BACKGROUND: Soluble suppression of tumorigenicity 2 (sST2) has emerged as a novel biomarker for heart failure, and serum sST2 concentrations could be increased in inflammatory diseases. We explored whether sST2... -
- CITED
-
- Close
- SHARE
-
- Close
